Recently Visited

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

Most Searched

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

No Matches Found

Rayzebio, Inc.

What does Rayzebio, Inc. do?

Rayzebio, Inc. is a small-cap biotechnology company with a market cap of approximately $3.81 billion, currently reporting a net profit loss of $18 million as of September 2023. The company has no dividend yield and negative key financial metrics, including a debt equity ratio of -0.94 and a return on equity of -11.92%.

Jun 22 2025 07:24 PM IST

Share Via

{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)

{{ra.stock_return.chgp}}%

{{ra.sensex_return.chgp}}%

Change%

Figures in Rs cr

How big is Rayzebio, Inc.?

As of Feb 27, Rayzebio, Inc. has a market capitalization of 3,814.02 million, classifying it as a Small Cap company, with net sales of 0.00 million and a net profit of -53.34 million over the latest four quarters.

Jun 22 2025 06:33 PM IST

Share Via

${{list.post_title_sep}}$

Share Via

Our weekly and monthly stock recommendations are here

Stock of the Week

Industry

Market Cap

Date of Entry

Entry Price

Target Price

{{sm.target_price }} ({{sm.performance_target }}%)

Holding Duration

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Week

Stock of the Month

{{sm.comp_name}} price as on {{sm.todays_date}}

₹{{sm.price_as_on}} ({{sm.performance}}%)

Industry

Market Cap

Date of Entry

Entry Price

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Month

Rayzebio, Inc.

How big is Rayzebio, Inc.?

{{list.post_title}}

{{list.post_title}}